C1q-producing TAMs were associated with an immunosuppressed TME in clear cell renal cell carcinoma (ccRCC), characterized by high expression of immune-checkpoint molecules (PD1, LAG3, PDL1 and PDL2) (44). This evidence concerns the gene PDCD1LG2 and clear cell renal carcinoma.